Clinical trials
Lupus Nephritis trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2007 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 11 |
| Completed | 10 |
| Active, not recruiting | 3 |
| Recruiting | 3 |
| Unknown status | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 6 |
| Alexion Pharmaceuticals, Inc. | 3 |
| Aurinia Pharmaceuticals Inc. | 2 |
| Biogen | 2 |
| Boehringer Ingelheim | 2 |
| Bristol-Myers Squibb | 2 |
| Corestemchemon, Inc. | 2 |
| Seoul National University Hospital | 2 |
| Alpine Immune Sciences, Inc. | 1 |
| Astellas Pharma Korea, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lupus Nephritis | 30 |
| Lupus Erythematosus, Systemic | 11 |
| Glomerulonephritis, IGA | 5 |
| Nephritis | 4 |
| Glomerulonephritis | 2 |
| Glomerulonephritis, Membranous | 2 |
| Glomerulosclerosis, Focal Segmental | 2 |
| Nephrosis, Lipoid | 2 |
| Proteinuria | 2 |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 |
Trials
Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.